| |
Company
Roster
|
|
Total
Insiders : |
19 |
|
|
|
Total
Direct Shares :
|
498,595 |
|
|
Total
Indirect Shares :
|
5,560,086 |
| |
%
Held by Insiders:
|
1.39% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Hassanein Waleed H |
|
2024-04-17 |
74,087 |
2024-04-17 |
469,359 |
| Khayal Tamer I |
|
2024-04-09 |
25,185 |
2024-04-09 |
25,827 |
| Gordon Stephen |
|
2024-04-01 |
23,299 |
|
0 |
| Tobin James R |
|
2024-03-01 |
1,193 |
2024-03-01 |
220,211 |
| Corcoran Nicholas |
|
2024-02-23 |
24,327 |
2023-02-20 |
0 |
| Basile Edward M |
|
2024-02-06 |
8,350 |
2019-05-06 |
0 |
| Provost Miriam |
|
2023-12-15 |
23,348 |
2020-12-11 |
0 |
| Weill David |
|
2023-08-29 |
13,693 |
2019-11-11 |
0 |
| Ranganath Anil P. |
|
2023-08-01 |
9,512 |
2023-08-01 |
0 |
| Kania Edwin M Jr |
|
2023-05-25 |
257,944 |
2023-05-25 |
46,142 |
| Raines Merilee |
|
2023-05-25 |
1,193 |
2023-05-25 |
0 |
| Lovell Stephanie |
|
2023-05-25 |
1,193 |
2022-11-22 |
0 |
| Gunderson Thomas James |
|
2023-05-25 |
1,193 |
2023-05-25 |
0 |
| Damme Laura |
VP, Clinical Affairs |
2023-02-20 |
5,685 |
2022-12-14 |
0 |
| Carey John F |
VP of Operations |
2023-02-01 |
14,120 |
2019-11-15 |
0 |
| Sullivan John F |
VP of Quality & Engineering |
2021-08-30 |
14,273 |
|
0 |
| Riva Capital Management Iii, Llc |
10% Owner |
2019-05-06 |
0 |
2021-02-09 |
2,624,712 |
| Lung Biotechnology Pbc |
10% Owner |
2019-05-06 |
0 |
2019-12-09 |
2,053,240 |
| Afeyan Noubar |
10% Owner |
|
0 |
2019-10-29 |
120,595 |
|
|
2.83 (3.17%) 
